๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Entecavir+adefovir versus lamivudine+adefovir or entecavir alone in lamivudine-resistant chronic hepatitis b: 96-week data from the define study

โœ Scribed by Heo, Jeong; Ahn, Sang Hoon; Kweon, Young-Oh; Kim, Byung-Ho; Chan, Sang Hoon; Horban, Young-Oh; Wongcharatrawee, Byung-Ho; Llamoso, Sang Hoon; Lee, Kwan Sik; Bargaje, Rahul


Book ID
122433029
Publisher
Elsevier
Year
2013
Tongue
English
Weight
66 KB
Volume
3
Category
Article
ISSN
0973-6883

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Efficacy of entecavir in patients with c
โœ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 287 KB ๐Ÿ‘ 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/